MoneyWorks4Me

Cipla informs about acquisition

16 Jul 2019 Evaluate

Cipla has informed that  Cipla (EU), UK, wholly owned subsidiary of the Company has entered into a joint venture agreement with Jiangsu Acebright Pharmaceutical Co. (Acebright), China on 15th July 2019 for incorporation of a company (JV Co.) in China.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1850.95
Dr. Reddys Labs. 1239.95
Cipla 1398.00
Lupin 2092.00
Zydus Lifesciences 1230.50
View more..